Vericel (VCEL) Cash from Operations (2010 - 2026)
Vericel's (VCEL) quarterly Cash from Operations came in at 16383000.0 in Q1 2026, up 148.23% year-on-year from 6600000.0 in Q1 2025, and up 9.12% quarter-over-quarter from 15014000.0 in Q4 2025.
Vericel (VCEL) Cash from Operations (2010 - 2026) Analysis & Trends
Vericel has disclosed Cash from Operations across 17 years of filings, most recently posting 16383000.0 for Q1 2026.
- Cash from Operations for Q1 2026 came in at 16383000.0, up 148.23% year-over-year; the trailing twelve-month figure through Mar 2026 was 61693000.0 (up 7.18% YoY), and the FY2025 annual result was 51910000.0, down 10.75% from the prior year.
- Cash from Operations came in at 16383000.0 for Q1 2026 at Vericel, up from 15014000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 22242000.0 in Q4 2024 to a low of 3143000.0 in Q2 2022.
- The 5-year median for Cash from Operations is 8214000.0 (2025), against an average of 10556117.65.
- Across the five-year window, Cash from Operations slumped 65.62% in 2022 and jumped 224.4% in 2023, its largest moves.
- Vericel's Cash from Operations stood at 6975000.0 in 2022, then soared by 44.6% to 10086000.0 in 2023, then soared by 120.52% to 22242000.0 in 2024, then sank by 32.5% to 15014000.0 in 2025, then advanced by 9.12% to 16383000.0 in 2026.
- The last three Cash from Operations figures came in at 16383000.0 (Q1 2026), 15014000.0 (Q4 2025), and 22082000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | 16.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.38 Mn |
| Mar 31, 2026 | 16.38 Mn |
| Dec 31, 2025 | 15.01 Mn |
| Dec 31, 2025 | 15.01 Mn |
| Sep 30, 2025 | 22.08 Mn |
| Sep 30, 2025 | 22.08 Mn |
| Jun 30, 2025 | 8.21 Mn |
| Jun 30, 2025 | 8.21 Mn |
| Mar 31, 2025 | 6.60 Mn |
| Mar 31, 2025 | 6.60 Mn |
| Dec 31, 2024 | 22.24 Mn |
| Dec 31, 2024 | 22.24 Mn |
| Sep 30, 2024 | 10.18 Mn |
| Sep 30, 2024 | 10.18 Mn |
| Jun 30, 2024 | 18.54 Mn |
| Jun 30, 2024 | 18.54 Mn |
| Mar 31, 2024 | 7.20 Mn |
| Mar 31, 2024 | 7.20 Mn |
| Dec 31, 2023 | 10.09 Mn |
| Dec 31, 2023 | 10.09 Mn |